BioSig Technologies, Inc. STEX Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s accounts receivable?
- BioSig Technologies, Inc. (STEX) reported accounts receivable of -$11K in Q1 2026.
- How has BioSig Technologies, Inc.'s accounts receivable changed year-over-year?
- BioSig Technologies, Inc.'s accounts receivable decreased by 110.1% year-over-year, from $109K to -$11K.
- What is the long-term trend for BioSig Technologies, Inc.'s accounts receivable?
- Over 2 years (2022 to 2024), BioSig Technologies, Inc.'s accounts receivable has grown at a 329.3% compound annual growth rate (CAGR), from $14K to $258K.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.